Current stage -Stage II Page 2 Posts on Medivizor
Navigation Menu

Current stage -Stage II Posts on Medivizor

The timing of first biopsy and its effect on prostate cancer reclassification

Posted by on Apr 3, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the influence of biopsy timing on prostate cancer reclassification during active surveillance.  The authors concluded that the timing of the first biopsy was not related to an increased risk of cancer reclassification, but prostate specific antigen (PSA) and body mass index (BMI – measured based...

Read More

Can sentinel lymph node dissection be used to identify patients who could benefit from further therapy?

Posted by on Mar 3, 2017 in Prostate cancer | 0 comments

In a nutshell The aim of the study was to examine if sentinel lymph node dissection (SLND) could be used to select patients with prostate cancer who would benefit from further pelvic radiation therapy and long-term androgen deprivation therapy (ADT). It was concluded that SLND could be used as a tool to determine whether patients should have more...

Read More

Can biopsies guided by multiple imaging techniques better detect disease progression?

Posted by on Dec 1, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the benefit of biopsies guided by multiple imaging techniques (scans that provide images of the interior of the body) in men managed with active surveillance. Researchers reported improved detection rates of disease progression when biopsies were guided by multiple imaging techniques. Some background Many men with...

Read More

Survival benefits for men treated with local therapies before starting chemotherapy

Posted by on Nov 21, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the benefits of administering local therapies before chemotherapy for prostate cancer. Researchers reported lower mortality risks for men treated with local therapies before chemotherapy. Some background Local therapies, such as surgery or radiation, are first-line treatments for localized (confined) prostate...

Read More

Examining the benefits of physical exercise during active surveillance

Posted by on Nov 14, 2016 in Prostate cancer | 0 comments

In a nutshell This review examined findings on lifestyle interventions for men with prostate cancer managed with active surveillance. The authors reported preliminary evidence on the benefits of physical exercise for men undergoing active surveillance. Some background Due to advances in the early detection of prostate cancer, many prostate tumors...

Read More

Risk factors, unfavorable disease and the implications for active surveillance in early-stage prostate cancer

Posted by on Oct 17, 2016 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the risks of unfavorable disease and predictors of adverse outcomes in men with Gleason score 3 + 4 prostate cancer and how this would affect active surveillance. The authors concluded that active surveillance is a potential treatment option in men with Gleason score 3+4, low PSA scores and low-stage...

Read More

Different radiation therapy schedules: Hyopfractioned EBRT is as effective as standard EBRT

Posted by on Oct 3, 2016 in Prostate cancer | 0 comments

In a nutshell This study compared the safety and effectiveness of external beam radiation therapy (EBRT) and hypofractioned EBRT (H-EBRT) for localized prostate cancer. Researchers reported no differences in survival or disease recurrence rates between high H-EBRT and EBRT. Some background Radiation therapy is a common treatment for localized...

Read More

Focal prostate radiotherapy in early prostate cancer

Posted by on Sep 19, 2016 in Prostate cancer | 0 comments

In a nutshell The main objective of this study was to review all data available on focal radiotherapy (FRT) for men with early prostate cancer. The authors concluded that FRT was an option in early prostate cancer but may not be as effective in intermediate-risk tumors. Some background Radiation therapy is an important part of prostate cancer...

Read More

High dairy intake after prostate cancer diagnosis may be associated with increased mortality risk

Posted by on Aug 7, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the association between dairy intake after prostate cancer diagnosis and mortality risk. Researchers reported increased mortality risk among men with high dairy intake after prostate cancer diagnosis.  Some background Advances in treatment and early detection of prostate cancer have increased survival and...

Read More